Lipid metabolism disorders are regarded as a significant factor of cardiovascular diseases pathogenesis that are associated with atherosclerosis, and cardiovascular death event. It is feasible to ...realize the project on establishing of regional lipid centers with aim of increased efficacy of patients treatment, with cardiovascular diseases and decrease of morbidity and mortality from cardiovascular diseases inRussian Federation.Aim. The aim of the Lipid center functioning — increased availability of highqualified cardiological and angioneurological care of patients with lipid metabolism disorder, and increase of efficacy of cardiovascular patient’s management.Material and methods. Lipid center of the KMAD-Yugra “CDCVS” has been established on the functional basis, at the consulting cardiological unit in January 2016. The tasks of the Center: diagnostics, treatment and follow-up of patients with complicated lipid disorders (incl. inherited), angioneurological pathology; conduction of federal registry of the familial hypercholesterolemia (FHCE) and other rare lipid metabolism disorders; education of clinicians and nurses; interaction with the authorities and patient societies.Results. Based upon the data ofLipidCenter, there are 2 registries ongoing: registry of a dynamical follow-up for angiology (regional); registry of FHCE (state level). Into the Russian FHCE registry, 30 patients included during a year, and into dynamic angioobservation — 318 patients. Taken high prevalence of the pathology in younger patients, we have developed and implemented an algorithm of the young acute coronary syndrome patients follow-up; developed and approved the algorithms of interaction of the in-patient and outpatient parts of specialized care for lipid disorder patients.Conclusion. Based on a year experience of the Lipid Center KMAD-Yugra “CDCVS” it is plausible to say that an implementation into the structure of medical institutions such departments among Russian Federation, makes it to establish effective organization of diagnostics and treatment of patients with lipid metabolism disorders, and is evidently clinically effective and economically expedient.
The aim of our research is to study associations of psychosocial factors with the probable hospital mortality according to the TIMI and Grace scales in patients with acute coronary syndrome living in ...the North. Materials and methods. 269 patients (female n = 57, n = 212 men) with acute coronary syndrome were examined, their average age was 56,0 ± 6,1 years (45-64 years). The complex of diagnostic studies and surveys of patients on a specially designed questionnaire consisting of general questions, the «AUDIT» test and the assessment of the psychological state of the individual was accomplished. An assessment of the severity of the coronary lesion on the SYNTAX scale was conducted; the calculation of the estimated hospital mortality rate on the TIMI and Grace scales was performed.Results. Male gender is associated with the development of alexithymia in a group of patients with a low and moderate risk of a possible hospital mortality rate on the Grace scale (r = 0.20, p <0.01). Continuance of residence in the North is associated with the development of myocardial infarction (r= 0.18, p <0.01) in the group of people with a low and moderate risk of probable hospital mortality. The direct associations of nonconventional factors with high risk of hospital-related mortality on the Grace scale in patients with acute coronary syndrome are high personal levels (OR = 1.593, 95% CI 1.373- 1.943, p = 0.027) and situational anxiety (OR = 1.728, 95% CI 1.037 -2.881, p = 0.036). The leading factors determining the severity of coronary artery disease on the SYNTAX scale in the group of patients with the high risk of possible hospital mortality according to the Grace scale are the low level of social integration (OR = 0.205, 95% CI 0.043-0.394, p = 0.012) and satisfaction with social support ( OR = 0.714, 95% CI 0.546-0.935, p = 0.014). Personal anxiety is associated with an increase in the incidence of alexithymia in high-risk patients for the probable hospital mortality rate on the TIMI scale (r = 0.40, p <0.01). Determining factors of the high risk of the probable hospital mortality on the TIMI scale are: the time from the moment of the onset of the pain syndrome to the admission of the patient to the hospital (OR = 0.580, 95% CI 0.338-0.995, p = 0.048) and low ejection fraction (OR = 0.930, 95% CI 0.875-0.988, p = 0.019).Conclusion. Directly determining nonconventional factors of high risk of possible hospital mortality on the Grace scale in patients with acute coronary syndrome living in the North are high levels of personal and situational anxiety. The age of patients and the continuance of stay in the North in patients with acute coronary syndrome do not significantly affect the level of probable hospital mortality on the Grace scale. The combination of indicators of long-term residence in the North and significant coronary bed lesion on the SYNTAX scale determine a high risk of a possible hospital mortality rate on the TIMI scale in patients with acute coronary syndrome.
Since the end of the 20th century, as by the results of epidemiological studies, there is broadly known concept of risk factors (RF), having become the fundamentals of cardiovascular prevention. ...Traditionally, there is distinction of conventional and non-conventional, or psychosocial, RF, among those emotional factors and chronic stressors. The impact of non-conventional RF on the diseases development, and primarily cardiovascular, is questionned, but is the most actual due to high mortality from cardiovascular diseases, and one of the most complicated as well. The article focuses on a review of known studies of the influence of non-conventional RF on the ischemic heart disease development, and an attempt is done to evaluate the influence of these factors on the development of acute coronary syndrome.
Acute and chronic steroid-refractory graft-versus-host disease (srGVHD) is a life-threatening complication of allogeneic stem cell transplantation. There are a number of reports on case series ...describing efficacy of ruxolitinib in both acute and chronic srGVHD. We conducted a prospective study (NCT02997280) in 75 patients with srGVHD (32 acute, 43 chronic, 41 adults, and 34 children). Patients with chronic GVHD had severe disease in 83% of cases, and acute GVHD patients had grade III-IV disease in 66% of cases. The overall response rate (ORR) was 75% (95% CI 57-89%) in acute GVHD and 81% (95% CI 67-92%) in chronic. Overall survival was 59% (95% CI 49-74%) in acute group and 85% (95% CI 70-93%). The major risk factors for lower survival were grade III-IV gastrointestinal involvement (29% vs 93%, p = 0.0001) in acute form and high disease risk score in chronic (65% vs 90%, p = 0.038). Toxicity was predominantly hematologic with 79% and 44% of grade III-IV neutropenia in acute and chronic groups, respectively. There was no difference between adults and children in terms of ORR (p = 0.31, p = 0.35), survival (p = 0.44, p = 0.12) and toxicity (p > 0.93). The study demonstrated that ruxolitinib is an effective option in acute and chronic srGVHD and can be used both in adults and children.
Aim. Russian multicenter register of familial hypercholesterolemia (FH) was transformed into Register of patients with FH and very high cardiovascular risk with insufficient effect of hypolipidemic ...therapy (RENESSANS Registry) in 2017 The aim of RENESSANS was maximal inclusion of patients not only with FH, but also those with atherosclerotic cardiovascular diseases (CVD), who did not achieve targeted level of low density lipoprotein cholesterol (LDL-C) using hypolipidemic drug therapy.Material and methods. The RENESSANS Registry is an open, national, observing study that includes patients with definite and probable (according to Dutch lipid clinic network and Simon Broome Registry criteria) heterozygous and homozygous FH, as well as patients of very high cardiovascular risk. There were designed two register forms: for patients with FH and for very high cardiovascular risk patients. Doctors filled out forms in paper and electronic variants. They took into consideration the risk factors of atherosclerosis and anamnesis of CVD, adherence to diet and hypolipidemic therapy. Concentrations of total cholesterol (TC), triglycerides (TG), high density lipoprotein cholesterol (HDL-C) were measured in blood serum in all centers. LDL-C level was defined according to Friedewald formula: LDL-C=TC-HDL-C-TG/2,2 (mmol/l).Results. The Registry consisted of 1208 FH patients and 497 patients with very high risk (average age 54±13 and 61±8, respectively, 37% men). Baseline levels of lipids were 9,4±2,3 and 6,9±1,5 mmol/l for TC, 6,6±2,1 and 4,5±1,3 mmol/l for LDL-C, respectively. The frequency of hypolipidemic therapy in both groups is 70%, while targeted level of LDL-C was achieved extremely rarely.Conclusion. The results show insufficient adherence and low effectiveness of standard hypolipidemic therapy both in patients with FH and very high cardiovascular risk. PCSK9 inhibitors are recommended for resistant hypercholesterolemia treatment. The RENESSANS Registry allows to improve FH diagnostics, to assess treatment effectiveness and choose patients who need treatment with PCSK9 inhibitors.
Relevance
. Allogeneic hematopoietic stem cell transplantation (allo-HSCT) makes it possible to treat severe malignant and non-malignant hematopoietic disorders system. Pulmonary complications (PC) ...occur in 40–60 % of patients after allo-HSCT. However to date, the effect of HSCT on functional and morphological pulmonary changes in recipients remains insufficiently studied.
The objective
of current study was to evaluate risk factors affecting long-term survival in children and adolescents after allo-HSCT.
Methods and materials
. The current study was both retrospective and prospective. The analysis included 362 patients with acute lymphoblastic leukemia (ALL) and acute myeloid leukemia (AML), aged 5 months to 18 years, who received allo-HSCT at Raisa Gorbacheva Memorial Research Institute for Pediatric Oncology, Hematology and Transplantation in 2000–2018. All the patients underwent chest computed tomography (CT). When detecting CT changes, we performed fibrobronchoscopy (FBS) with microbiological examination of bronchoalveolar lavage (BAL).
Results
. PC were diagnosed in 124 patients (64 %) who received allo-HSCT in 2014–2018. Decrease of overall survival (OS) is associated with PC development during the first year after allo-HSCT(р<0,001).The development of early PC in remission of the underlying disease significantly affected OS (p=0.001).The probability of PC development is 2.26 times higher in patients older than 9 years (p=0.006). When comparing the intensity of conditioning regimens (MACvsRIC) in remission of the underlying disease, we did not get significant differences in the incidence of PC (p>0.05). Graft source, donor type, HLA-compatibility, recipient gender did not affect the incidence of PC (p>0.05). When using graft-versus-host disease (GVHD) prophylaxis (ptCYvsATG), the 5-year OS in patients without PC was 78.8 % and 62.8 %respectively. The 5-year OS in patients with PC was 51.8 % and 42.4 % respectively (р=0.007). Decrease of OS in patients with PC is associated with chGVHD(58.3 %,) (р=0.03).
Conclusion
. Pulmonary complications (infectious and non-infectious) in allo-HSCT recipients are more likely to occur in the first year after transplantation. Among bacterial pathogens, the predominance of Gr(-) flora remains. The incidence of pulmonary complications was significantly lower when using ptCY as a prevention of GVHD.
A case of successful transcatheter aortic valve implantation in a patient with degenerative stenosis is presented. The first results in the immediate postoperative period are described.
The prevalence of hepatitides B and C was evaluated in 140 patients treated by hemodialysis. Almost half of patients (48%) had acute hepatitis B which completely resolved. Acute hepatitis B was ...detected in 6% in the course of observation. In 6% chronic hepatitis B was diagnosed, and in 24% chronic hepatitis C. A combination of hepatitides B and C was diagnosed in 2% patients. Only 12% patients were not infected with hepatitis. Genotype 1b predominated in patients with HCV infection (73%); genotypes 1a, 21, and 3a were equally incident (9%). Replication of HBV and HCV in patients with uremia under conditions of hemodialysis was detected in 83 and 86% patients, respectively. Relationship between HBV and HCV infection and the duration of hemodialysis treatment was analyzed. The percentage of non-infected patients persistently decreased, and the time course of HBV and HCV infection was different. Infection with HBV after the beginning of hemodialysis occurred sooner (16.0 +/- 4.0 months) than with HCV (30.2 +/- 4.6 months, p < 0.04). The levels of SGPT and SGOT in patients with various manifestations of HBV and HCV infection treated by hemodialysis were followed up.
PDF
